EATG » Access

Access

MSF challenges Gilead’s patent application for hepatitis C combination treatment in China, to bring down prices

Gilead recently launched one of these drugs for $100/pill in China Geneva, 18 December 2017 – The international medical humanitarian organisation, Médecins Sans Frontières (MSF) has filed a legal patent…

UNAIDS and IOM renew partnership agreement to promote access to HIV services for migrants and crisis-affected populations

GENEVA, 8 December 2017—UNAIDS and the International Organization for Migration (IOM) today signed a new cooperation agreement to promote access to HIV prevention, treatment, care and support services for migrants,…

Medicines access group takes aim at Sovaldi patents

Two new patent challenges have been launched by the New York-based patient access and public health activist I-MAK - the Initiative for Medicines, Access & Knowledge. The actions are being…

Argentina: Sofosbuvir patent rejected

Hepatitis C: In Argentina INPI rejected a key patent on sofosbuvir Argentina has made an important step forward to protect local production of generics of an essential medicine to treat…

Romania to double 2018 budget for TB

Following pressure from civil society, the Romanian Ministry of Health announced that it plans to double the budget of the National TB program in 2018 "to ensure access to diagnosis…

HIV i-Base: November/December 2017 issue of HIV Treatment Bulletin now online

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base every two months. HTB reviews the most important advances in the clinical management of HIV and access to…

Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines after Brexit

Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit The associations representing…

Medicines Excitement in the Netherlands – New Health Minister announces firm action on “absurd” medicines pricing and gets the European Medicines Agency

November 24, 2017: The new Minister of Health of the Netherlands, Bruno Bruins, came in guns blazing when he put the pharmaceutical industry on notice and announced on 22 November…

Open letter to the Romanian MoH to focus on TB

The Romanian Health Observatory, supported by the Romanian Angel Appeal Foundation (RAA) under the Global Fund programme, has published “The Crisis of Anti-TB Medicines in Romania”, a comprehensive and evidence-based…

Danish court invalidates Gilead SPC

The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. On October 26, the court rejected Gilead’s motion for an injunction against generics…